Pulmonary embolism tracking from emergency care to long-term follow-up
Part of Heart & circulation, Lungs & breathing clinical trials.
This study follows people who have had a pulmonary embolism (a blood clot in the lungs) to understand their health over time and improve future care. It does not test a new treatment but collects information to learn more about recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with a pulmonary embolism (blood clot in the lungs). The doctor may have found it using a CT scan, a lung scan, or other imaging tests.
- If you had a severe clot, the diagnosis may have been made using ultrasound at the bedside.
- For the part of the study that looks back at records, your medical history must include details about your initial diagnosis and symptoms.
- You (or your legal representative) must give permission, or the study may include you if you cannot be reached, following legal rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who may have a blood clot in the lung (pulmonary embolism) or leg (deep vein thrombosis), or who were found to have a clot by chance. It aims to improve how doctors diagnose, manage, and estimate risk, which may lead to better, more tailored care for you.
This study looks at repeated scans and tests for people who have had a pulmonary embolism (PE) — a blood clot in the lungs. It aims to improve how doctors monitor recovery and decide on treatment.
This study tests a new catheter-based device that delivers clot-dissolving medicine directly to the blood clot in the lungs for people with a moderate-risk pulmonary embolism. The goal is to improve blood flow to the lungs and relieve symptoms with a lower dose of medication than standard care.
This trial tests a procedure that uses ultrasound to guide a catheter that delivers clot-dissolving medicine directly to a blood clot in the lungs. It is for people who have a pulmonary embolism that causes some heart strain but who are not in shock.
This study compares two ways of following up after a non-severe pulmonary embolism: standard medical care alone versus intensive monitoring that includes an advanced practice nurse. The goal is to see if the nurse-led follow-up improves your recovery and quality of life.
This trial looks at how people do after an acute pulmonary embolism (a blood clot in the lungs). It aims to understand real-world outcomes over follow-up and may help improve how care teams track patients after treatment.
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.